 |
|
|
| |
Prediction accuracy of the NASHmap algorithm designed to screen for presence of NASH
|
| |
| |
AASLD 2020 Nov 11-16
Reported by Jules Levin
Brenda Reinhart1, Matt Docherty2, Maria-Magdalena Balp3, Andreas Tietz3, Jennifer Cai4, Carolle Kinyua5, Marcos C Pedrosa3, Jörn M Schattenberg61ZS Associates, Zurich, Switzerland; 2ZS Associates, Philadelphia, PA, USA; 3Novartis Pharma AG, Basel, Switzerland; 4Novartis Pharmaceuticals Inc., East Hanover, USA; 5Novartis South Africa (Pty) Ltd, Waterfall City, South Africa; 6Department of Medicine, University Medical Center Mainz, Germany
|
| |
|
|
|
|
|
